INSPIRE MEDICAL SYSTEMS INC
INSPNYSETrading Snapshot
- Day Range
- $892.87 β $915.51
- 52-Week Range
- $38.91 β $147.03
- Volume
- $1.88B
- Avg Volume
- $1.49B
- Shares Outstanding
- 28.9M
- Next Earnings
- Nov 26, 2026
Fundamentals Snapshot
- Annual Revenue
- $912M
- Last Q Revenue
- $201M
- P/E Ratio
- 15.0
- P/S Ratio
- 2.3x
- EPS (TTM)
- $4.68
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β5.0%
Why Investors Own INSP
- βHigh-growth profile β revenue up +1.1% YoY with expanding US Equity exposure.
- βHealthy economics β 72% gross margin and 18% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
INSPIRE MEDICAL SYSTEMS INC
INSPAbout INSPIRE MEDICAL SYSTEMS INC
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
INSPIRE MEDICAL SYSTEMS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift INSP price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
INSPIRE MEDICAL SYSTEMS INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.